Opaleye Management Inc., Ten Percent Owner at Harrow Health, holds 12.79M shares in Codexis (Ticker: CDXS), holds 2.85M shares in Eton Pharmaceuticals (Ticker: ETON), holds 3.90M shares in Harrow Health (Ticker: HROW). Most recently, Opaleye Management Inc. Bought ― shares of Codexis on Aug 04, 2025 for an estimated value of 227.92K.
What was Opaleye Management Inc.’s latest transaction?
Opaleye Management Inc. latest transaction was an Informative Buy of $227.92K.
What was Opaleye Management Inc.'s most profitable transaction?
Opaleye Management Inc.’s most profitable transaction was an Informative Buy of OCUL stock on January 2, 2020. The return on the trade was 424.00%.
What is Opaleye Management Inc.'s role in Harrow Health?
Opaleye Management Inc.'s role in Harrow Health is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.